Tag: facility in Songdo
Samsung Biologics to add end-to-end mRNA vaccine manufacturing capability to its portfolio of services
Contract development and manufacturing organisation (CDMO) Samsung Biologics has unveiled plans to add mRNA vaccine drug substance (DS) manufacturing capability to the current facility...
Featured Article
APS Industrial brings Siemens’ next-gen PLC to Aussie manufacturers
As the manufacturing industry advances towards greater automation and digitalisation, companies are seeking smarter and more efficient control solutions to enhance their operations.
